1. Apabetalone, a selective BET protein inhibitor, reduces ischemic cardiovascular events and hospitalization for heart failure in patients with acute coronary syndrome and type 2 diabetes. (25th November 2020) Authors: Ray, K.K; Nicholls, S.J; Buhr, K.A; Ginsberg, H.N; Kalantar-Zadeh, K; Johansson, J.O; Kulikowski, E; Toth, P.P; Wong, N; Sweeney, M; Schwartz, G.G Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High risk US adults with untreated hyperlipidaemia in NHANES: estimated reduction in cardiovascular events with statin treatment. (25th November 2020) Authors: Toth, P.P; Palmer, M.K Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Increased particle size of triglyceride remnant lipoproteins, but not their plasma concentration or lipid content, augment risk prediction of incident diabetes: prospective results from ELSA-Brasil. (25th November 2020) Authors: Carvalho, L.S; Bensenor, I.M; Lotufo, P.A; Duncan, B.B; Blaha, M.J; Toth, P.P; Jones, S.R; Santos, R.D; Sposito, A.C Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗